Poor or intermediate risk Advanced Renal Cell Carcinoma (aRCC)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06186 | Ipilimumab | A human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB06186 | Ipilimumab | Cytotoxic T-lymphocyte protein 4 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|